Article
Diagnosis and Treatment Options for T2-Low Asthma.
The journal of allergy and clinical immunology. In practice - 1 Jul 2025
Thomas Dennis, Hamada Yuto, Gibson Peter, Brightling Chris E, Castro Mario, Heaney Liam G
Abstract excerpt
Type 2 (T2)-low asthma is characterized by the absence of T2-mediated eosinophilic airway inflammation. The diagnosis and prevalence of T2-low asthma are complicated by the absence of specific biomarkers, varied cutoffs of existing biomarkers, and biomarker suppression by corticosteroids. The substantial disease burden of T2-low asthma can be attributed to comorbidities, including obesity. Type 2-low asthma...
Read the complete abstract on PubMedTopics
- Humans
- Asthma
- Adrenal Cortex Hormones
- Obesity
- Anti-Asthmatic Agents
- Comorbidity
- Azithromycin
